Browsing by Subject Neoplasm Staging

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 62  next >
Issue DateTitleAuthor(s)
2017A BCR-ABL1 cutoff of 1.5% at 3 months, determined by the GeneXpert system, predicts an optimal response in patients with chronic myeloid leukemia.
2017-10A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
2016-01Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future.
2017-01American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy.
2015-01Are we ready for conservative treatment in ovarian cancer?Utrilla-Layna, Jesus; Zapardiel, Ignacio
2015-08Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.
2015-12Biliary tract cancers: SEOM clinical guidelines.
2015-12Clinical guideline SEOM: hepatocellular carcinoma.
2018Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain.
2016Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer.
2017-04-18Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer.
2015-03-30ColoLipidGene: signature of lipid metabolism-related genes to predict prognosis in stage-II colon cancer patients.
2015-03-13Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature.
2015-10Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone.
2015-05Defining breast cancer intrinsic subtypes by quantitative receptor expression.
2017Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
2017-02Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial.
2016-11-15Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.
2017-01Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study.
2017Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.